We are live on ! Find out more
PBYI icon

Puma Biotechnology
PBYI

84 hedge funds and large institutions have $1.01B invested in Puma Biotechnology in 2013 Q2 according to their latest regulatory filings, with 84 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

79.12% more ownership

Funds ownership: 0% → 79.12% (+79%)

Holders
84
Holders Change
+84
Holders Change %
–
% of All Funds
2.73%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
84
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PBYI Hedge Fund Activity: Q2 2013 in Review

84 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q2 2013, worth a combined $1.01B.

Buyers outnumbered sellers: 84 funds opened new PBYI positions and 0 closed out — a net gain of 84 holders — while 0 added to existing stakes and 0 trimmed.

  • 84 institutional investors held Puma Biotechnology (PBYI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.01B of Puma Biotechnology stock for Q2 2013.
  • 84 funds opened new Puma Biotechnology positions in Q2 2013 and 0 closed out, a net change of +84 holders.

Based on aggregated 13F filings for Q2 2013.